JAN 2022 (Q1 & 2) – INSIDE THIS ISSUE
Optishield New Product Launch Trial for Tomofat Oil Finsource Credit [...]
初上市估价不高 宏诚生科WC博母股反弹/温世麟
宏诚生科（SUNZEN，0148，创业版）的新凭单宏诚生科WC（SUNZEN-WC），在上周三（9月21日）开始在马交所上市。该凭单是宏诚生科通过发红股方式，以每2股送1凭单的比率派发给股东。SUNZEN-WC在上市后，在5.5仙和8仙之间波幅，并在上周五以7仙结束交易。该公司母股在上周五，则以19.5仙闭市。
Sunzen Biotech hopes to post record earnings in FY22
SHAH ALAM: Sunzen Biotech Bhd hopes to achieve record earnings [...]
Sunzen eyes return to profitability
KUALA LUMPUR: Sunzen Biotech Bhd expects to return to profitability [...]
Sunzen to product healthcare, beauty products at Selangor plant
KUALA LUMPUR: Sunzen Biotech Bhd will manufacture healthcare and beauty [...]
Sunzen Biotech proposes bonus issue of 409 million warrants
KUALA LUMPUR (Feb 16): Sunzen Biotech Bhd has proposed to [...]
OCT 2021 – INSIDE THIS ISSUES
Masofilm New Product Launch Sunzen 4th Quarter Activities Ecolite Activity [...]
Sunzen Biotech On Track To Return To The Black
Sunzen Biotech Bhd is on track to break even this year [...]
宏誠集團 核心業務表現亮眼
宏诚集团（SUNZEN GROUP）将通过业务间资源整合，发挥协同作用，以期未来盈收能力进一步得到加强。 宏诚集团的多角化经营模式，由早期的动物保健品领域，到近年来陆续透过购并，将多角化触手伸向养生保健、燕窝出口及燕窝衍生制品、融资／贷款服务、线上微商、移动电商服务模式，注重产品品质和品牌开发，致力为集团创造新的投资机会和盈利点。 Read More
April 2022 – INSIDE THIS ISSUE
TOMOFAT EGGS Product New Launch Sunzen’s Activities in 1st Quarter [...]
